Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tais H Kasai-Brunswick

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Frontiers in Pharmacology|April 29, 2021
Cell-Based Therapies for Heart FailureAntonio Carlos Campos de Carvalho, Tais H Kasai-Brunswick, Adriana Bastos Carvalho
Cellular and Molecular Life Sciences : CMLS|October 26, 2022
Anthracycline-induced cardiotoxicity and cell senescence: new therapeutic option?Fernando A C Seara, Tais H Kasai-Brunswick, Jose H M Nascimento, et al.
Cells|July 25, 2019
Proteomics in the World of Induced Pluripotent Stem CellsRafael Soares Lindoso, Tais H Kasai-Brunswick, Gustavo Monnerat Cahli, et al.
International Journal of Molecular Sciences|March 25, 2022
Early Effects of Extracellular Vesicles Secreted by Adipose Tissue Mesenchymal Cells in Renal Ischemia Followed by Reperfusion: Mechanisms Rely on a Decrease in Mitochondrial Anion Superoxide ProductionJarlene A Lopes, Federica Collino, Clara Rodrigues-Ferreira, et al.
Regenerative Medicine|December 24, 2010
Safety of autologous bone marrow mononuclear cell transplantation in patients with nonacute ischemic strokeValeria Battistella, Gabriel R de Freitas, Lea Mirian Barbosa da Fonseca, et al.
Journal of Cellular and Molecular Medicine|February 18, 2014
Reprogramming to a pluripotent state modifies mesenchymal stem cell resistance to oxidative stressKarina D Asensi, Rodrigo S Fortunato, Danúbia S dos Santos, et al.
Stem Cell Research|May 12, 2019
Generation of four patient-specific pluripotent induced stem cell lines from two Brazilian patients with amyotrophic lateral sclerosis and two healthy subjectsFernanda Gubert, Juliana F Vasques, Tatiane D Cozendey, et al.
Stem Cell Research|July 14, 2019
Generation of patient-specific pluripotent induced stem cell line UFRJi007-A from a Brazilian familial amyotrophic lateral sclerosis patientFernanda Gubert, Juliana F Vasques, Tatiane D Cozendey, et al.
Stem Cell Research & Therapy|August 23, 2014
Improvement of cardiac function by placenta-derived mesenchymal stem cells does not require permanent engraftment and is independent of the insulin signaling pathwayJuliana A Passipieri, Tais H Kasai-Brunswick, Grazielle Suhett, et al.
Scientific Reports|December 18, 2019
R534C mutation in hERG causes a trafficking defect in iPSC-derived cardiomyocytes from patients with type 2 long QT syndromeFernanda C P Mesquita, Paulo C Arantes, Tais H Kasai-Brunswick, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Frontiers in Pharmacology|April 29, 2021
Cell-Based Therapies for Heart FailureAntonio Carlos Campos de Carvalho, Tais H Kasai-Brunswick, Adriana Bastos Carvalho
Cellular and Molecular Life Sciences : CMLS|October 26, 2022
Anthracycline-induced cardiotoxicity and cell senescence: new therapeutic option?Fernando A C Seara, Tais H Kasai-Brunswick, Jose H M Nascimento, et al.
Cells|July 25, 2019
Proteomics in the World of Induced Pluripotent Stem CellsRafael Soares Lindoso, Tais H Kasai-Brunswick, Gustavo Monnerat Cahli, et al.
International Journal of Molecular Sciences|March 25, 2022
Early Effects of Extracellular Vesicles Secreted by Adipose Tissue Mesenchymal Cells in Renal Ischemia Followed by Reperfusion: Mechanisms Rely on a Decrease in Mitochondrial Anion Superoxide ProductionJarlene A Lopes, Federica Collino, Clara Rodrigues-Ferreira, et al.
Regenerative Medicine|December 24, 2010
Safety of autologous bone marrow mononuclear cell transplantation in patients with nonacute ischemic strokeValeria Battistella, Gabriel R de Freitas, Lea Mirian Barbosa da Fonseca, et al.
Journal of Cellular and Molecular Medicine|February 18, 2014
Reprogramming to a pluripotent state modifies mesenchymal stem cell resistance to oxidative stressKarina D Asensi, Rodrigo S Fortunato, Danúbia S dos Santos, et al.
Stem Cell Research|May 12, 2019
Generation of four patient-specific pluripotent induced stem cell lines from two Brazilian patients with amyotrophic lateral sclerosis and two healthy subjectsFernanda Gubert, Juliana F Vasques, Tatiane D Cozendey, et al.
Stem Cell Research|July 14, 2019
Generation of patient-specific pluripotent induced stem cell line UFRJi007-A from a Brazilian familial amyotrophic lateral sclerosis patientFernanda Gubert, Juliana F Vasques, Tatiane D Cozendey, et al.
Stem Cell Research & Therapy|August 23, 2014
Improvement of cardiac function by placenta-derived mesenchymal stem cells does not require permanent engraftment and is independent of the insulin signaling pathwayJuliana A Passipieri, Tais H Kasai-Brunswick, Grazielle Suhett, et al.
Scientific Reports|December 18, 2019
R534C mutation in hERG causes a trafficking defect in iPSC-derived cardiomyocytes from patients with type 2 long QT syndromeFernanda C P Mesquita, Paulo C Arantes, Tais H Kasai-Brunswick, et al.
Pageof 2